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Abstract
Purpose The purpose of this study was to identify and
evaluate risk factors of avascular necrosis (AVN) after
closed treatment for developmental dysplasia of the hip
(DDH).
Methods A retrospective review of children diagnosed
with DDH at a tertiary-care children’s hospital between
1986 and 2009 was performed. The presence of AVN was
assessed according to Salter’s classification system.
Results Eighty-two affected hips in 70 children with an
average age of 10 months at closed reduction (range
1–31 months) and 5 years (range 2–19 years) of follow-up
met the inclusion criteria. Twenty-nine (of 82, 35 %)
affected hips developed AVN. The use of pre-reduction
traction (p = 0.019) increased the risk of AVN, while
preoperative Pavlik harness or brace trial (p = 0.28),
presence of ossific nucleus at the time of closed reduction
(p = 0.16), and adductor tenotomy (p = 0.37) were not
significant factors. Laterality (right vs. left) was also not a
significant risk factor (p = 0.75), but patients who under-
went closed reduction for bilateral DDH were less likely to
develop AVN (p = 0.027). Overall, the degree of abduc-
tion did not affect the rate of AVN (p = 0.87). However, in
patients treated with closed reduction younger than
6 months of age, the rate of AVN was increased with
abduction C50 (9/15, 60 %) compared to abduction\50
(0/8, 0 %) (p = 0.007). Patients who developed AVN were
more likely to require subsequent surgery (p = 0.034) and
more likely to report a fair/poor clinical outcome
(p = 0.049).
Conclusions The risk of AVN (35 %) following closed
reduction and spica casting for DDH is high. The degree of
abduction in spica casts appears to be a risk factor in
patients B6 months old. The authors recommend that
abduction in spica casts should be limited to \50 in
children younger than 6 months of age.
Level of evidence IV.
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Introduction
Developmental dysplasia of the hip (DDH) has an esti-
mated incidence of 1.5–20 per 1000 births [1]. Closed
reduction plus spica cast application has a success rate as
high as 95 %, but complications do occur [2–10]. Com-
plication rates have been reported as high as 79 %, and
avascular necrosis (AVN) has proven to be particularly
problematic [3, 5, 10–15]. This major complication has a
reported incidence of up to 47 % and can result in limb
length discrepancy, joint incongruity, persistent subluxa-
tion, coxa valga, and other sequelae [6, 8, 16–24]. These
changes can drastically affect hip function and may impact
overall health and quality of life [18, 22–26].
The exact etiology of AVN is unknown but likely
multifactorial, with vascular and iatrogenic components
[18, 26–28]. Prior literature identifies both a number of risk
& Paul D. Choi
pchoi@chla.usc.edu
1 Children’s Orthopaedic Center, Children’s Hospital Los
Angeles, 4650 Sunset Boulevard, Mailstop #69, Los Angeles,
CA 90027, USA
2 Department of Orthopaedic Surgery, University of California
Los Angeles, Los Angeles, CA, USA
3 Department of Orthopaedic Surgery, Children’s Hospital of
Philadelphia, Philadelphia, PA, USA
123
J Child Orthop (2016) 10:185–192
DOI 10.1007/s11832-016-0743-7
factors, such as hip abduction angle, and protective factors,
such as early age at reduction, the presence of an ossific
nucleus, and the use of an adductor tenotomy in the
development of AVN [18–20, 22–25, 29–31]. Although
some of these factors have been previously analyzed, the
significance of each in the development of AVN has
remained unclear. The purpose of this study was to identify
and evaluate the risk factors and outcomes associated with
AVN after closed reduction and spica cast application for
children with DDH.
Materials and methods
After institutional review board approval, initial screening
using International Classification of Diseases, Ninth Revi-
sion, Clinical Modification (ICD-9-CM) codes for the
diagnosis of DDH and Current Procedural Terminology
(CPT) codes for closed reduction between January 1986
and January 2009 identified 287 consecutive patients at a
single tertiary pediatric center. Inclusion criteria were a
diagnosis of a subluxated or dislocated hip requiring closed
reduction under general anesthesia in the operating room
plus spica cast application, computed tomography (CT)
scan following reduction, and a minimum of 18 months of
clinical and radiographic follow-up. Exclusion criteria
were a diagnosis of neuromuscular disease or teratologic
dislocations, history of open reduction as initial manage-
ment, incomplete radiographic data, history of multiple
closed reductions, and onset of AVN after subsequent
surgery.
Retrospective electronic and physical chart reviews
were performed to identify demographic information,
clinical data, and length of follow-up. The need for sub-
sequent procedures, whether open reduction of the hip or a
reconstructive procedure (acetabular augmentation and/or
femoral osteotomy), was also recorded. Images were
reviewed by a single observer not involved in patient
treatment. The initial preoperative plain radiographs were
reviewed for the presence of a proximal femoral ossific
nucleus. CT scans following closed reduction and spica
casting were reviewed to measure the hip abduction angle
by the method described by Browning et al. [32]. Plain
radiographs at 1 year and final follow-up were reviewed to
look for the development of AVN and to measure the
acetabular index. The presence of AVN was evaluated
using Salter’s criteria [18]. Temporary irregular ossifica-
tion, as defined by Salter et al., was not considered AVN
[18]. Clinical outcomes were graded as excellent, good,
fair, or poor based on the criteria devised by Brougham
et al. [22]. Radiographic outcomes were graded based on
the acetabular index, which was measured manually.
Acetabular dysplasia was defined by an acetabular index
C30 in the affected hip at 2 years of age [33].
Statistical analysis was performed using Stata 12 (Sta-
taCorp LP, College Station, TX) and Microsoft Excel
(2010). Univariate statistical analysis was performed by
two-tailed Student’s t-test and the Chi-squared test or
Fisher’ exact test in the case that values were too small for
Chi-squared. A general estimating equation (GEE) was
used to analyze the association of AVN with multiple
variables while accounting for the cases of bilateral
affected hips. Logistic multivariate regression was used for
subgroup (closed reduction within six months of age)
analysis, as the population was too small to use a GEE.
Variables were included in either multivariate model if the
univariate p-value \0.15 [34]. p-Value were considered
significant at p\ 0.05. Univariate p-values are given for
variables that did not meet the multivariate inclusion
threshold (p\ 0.15). Effect sizes are reported as odds ratio
(OR) or risk difference (RD) when unable to calculate the
OR due to a zero being included in the calculation. Fig-
ures were created using Adobe Photoshop CS6 (Adobe
Systems, San Jose, CA).
Results
Seventy patients with 82 hips underwent closed reduction
under general anesthesia and spica cast application for a
subluxated or dislocated hip and met the inclusion criteria.
Sixty-two of these patients (89 %) were female and eight
(11 %) were male. The left hip was involved in 40 patients,
the right in 18 patients, and both hips in 12 patients. The
mean age at the time of diagnosis was 8.0 months (range
0–31 months) and the mean age at the time of closed
reduction was 10 months (range 1–31 months). The mean
length of follow-up was 5 years (range 2–19 years).
Twenty-two (of 70, 31 %) had undergone Pavlik harness
or hip abduction orthosis treatment prior to the closed
reduction procedure under general anesthesia (duration
1–12 weeks) (Table 1). In general, Pavlik harness or hip
abduction orthosis was used as the initial treatment for a
subluxated or dislocated hip in younger patients (younger
than 6–9 months of age). Traction was used in 17 patients





Pavlik harness or abduction brace 22 (1–12 weeks) 29
Bradford/Bryant/gallows-type traction 17 (3–14 days) 21
Adductor tenotomy 52 62
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(of 70, 24 %) for 3–14 days at weights ranging from 1 to
10 pounds (11–38 % body weight traction), with ages
ranging from 2 to 15 months. Three types of traction were
used: Bradford traction (longitudinal type of traction),
Bryant traction (overhead traction), and gallows-type
traction (also overhead). The proximal femoral ossific
nucleus was present in 48 (of 82, 59 %) affected hips on
plain radiographs at the time of the closed reduction pro-
cedure. Fifty-two patients (of 70, 74 %) underwent
adductor tenotomy during the closed reduction procedure
under general anesthesia prior to spica cast application.
AVN of the femoral head developed in 29 of 82 affected
hips (35 %). AVN developed in 28 of 70 patients (40 %).
Twenty-one of these patients (75 %) were female and
seven (25 %) were male. The left hip was involved in 18
patients, the right in nine, and both hips in one patient.
Male patients were significantly more likely to develop
AVN compared to female patients (p = 0.027). Patients
with bilateral DDH were less likely to develop AVN
(p = 0.027), while laterality (right vs. left) did not appear
to affect the risk of AVN (p = 0.85).
No significant difference in the development of AVN
was seen whether patients had undergone prior Pavlik
harness or hip abduction orthosis treatment (p = 0.28) or
whether adductor tenotomy was performed during the
closed reduction procedure (p = 0.37). The use of pre-re-
duction traction appeared to increase the risk of AVN, with
AVN developing in 65 % (11/17) of patients who under-
went traction versus 32 % (17/53) who did not
(p = 0.019). There was no significant difference in the
rates of AVN in patients who underwent longitudinal
versus overhead (vertical) traction (p = 0.71). Four of the
17 patients (five affected hips, one bilateral case) that
underwent pre-reduction traction had undergone and failed
brace treatment (Pavlik harness or hip abduction orthosis).
A prior history of brace treatment did not affect the risk of
AVN in patients who underwent pre-reduction traction; the
risk of AVN remained increased. In pre-reduction patients
with history of brace treatment, three (of five) hips (in two
of four patients) developed AVN, while in pre-reduction
patients without history of brace treatment, nine (of 16)
hips (in 9 of 13 patients) developed AVN (p[ 0.99).
No significant difference in the risk of AVN was seen
whether proximal femoral ossific nucleus was present or
not at the time of closed reduction (p = 0.16). The hip
abduction angle also did not appear to affect the risk of
AVN (p = 0.87) in the overall study population. How-
ever, in patients B6 months of age at the time of the
closed reduction procedure, hip abduction angle C50 did
significantly increase the risk of AVN [p = 0.007, RD
0.6, 95 % confidence interval (CI) 0.19–0.80] (Fig. 1).
The proximal femoral ossific nucleus was present in six
(of 23) hips that underwent closed reduction younger
than 6 months of age; 42 (of 59) hips that underwent
closed reduction were older than 6 months. The risk of
AVN remained increased in this group of patients
B6 months of age at the time of closed reduction and hip
abduction angle C50 whether proximal femoral ossific
nucleus was present or not. In patients younger than
6 months old and hip abduction angle C50, eight (of
12) hips (in seven of 11 patients) developed AVN when
the ossific nucleus was absent, compared to one (of
three) hips (in one of three patients) when the ossific
nucleus was present (p = 0.53). Furthermore, in patients
without ossific nuclei (29 of 70 patients), hip abduction
angle C50 did not significantly increase the risk of
AVN (p = 0.29). The results of univariate and multi-
variate analyses to determine the significance of risk
factors of AVN (including effect sizes and confidence
intervals) can be found in Table 2.
Fig. 1 Five-month-old female patient diagnosed with developmental
dysplasia of the left hip. The patient underwent failed pre-reduction
Pavlik harness treatment for eight days and did not have ossific nuclei
present at the time of closed reduction. a Following an adductor
tenotomy, closed reduction, and spica cast application, postoperative
computed tomography (CT) revealed the left hip to be abducted to
62. b Radiographs at 1-year follow-up indicate deformity of the left
hip indicative of avascular necrosis (AVN). The patient’s final clinical
score was graded as fair
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Outcome
Sixteen of 70 patients (23 %) underwent subsequent sur-
gery, with 13 acetabular augmentation procedures (Salter
or Dega pelvic osteotomy), one femoral osteotomy, one
acetabular augmentation ? femoral osteotomy ? open
reduction, and one open reduction. Patients who developed
AVN were significantly more likely to require subsequent
surgery (p = 0.034). Ten (of 28, 36 %) of the patients who
developed AVN after the closed reduction procedure ulti-
mately required subsequent surgery (eight acetabular aug-
mentation, one acetabular augmentation ? femoral
osteotomy ? open reduction, one open reduction), com-
pared to six (of 42, 14 %) of the patients without AVN
(five acetabular augmentation, one femoral osteotomy)
(Table 3). Overall, of the 82 affected hips, 71 were clini-
cally graded as good to excellent (55 excellent, 16 good),
while 11 hips were graded as fair to poor (11 fair, 0 poor).
Patients with AVN were significantly more likely to report
fair to poor clinical outcome (8/29) than patients without
AVN (3/53) (p = 0.049) (Table 4). The mean acetabular
index of affected hips at final follow-up was 19.4 (range
2–36). The development of AVN did not result in a
higher acetabular index (mean acetabular index in AVN
patients = 20.0; in non-AVN patients = 19.1)
(p = 0.59). The results of the univariate and multivariate
analyses to determine the relationship between AVN and
clinical and radiographic outcomes can be found in
Table 5.
Discussion
AVN of the femoral head is a known complication fol-
lowing closed reduction and spica cast application for
DDH (a subluxated or dislocated hip), with rates reported
as high as 47 % [22]. Earlier studies have cited various
possible risk factors of AVN, including age, gender, lat-
erality, absence of proximal femoral ossific nucleus, use of
pre-reduction traction, preliminary/history of hip abduction
Table 2 Risk factors of avascular necrosis (AVN): results of univariate and multivariate analyses to determine significance
Risk factors Univariate p-value Odds ratio 95 % CI Multivariate p-value Odds ratio 95 % CI
Male gender 0.011 16.6 1.92–142.58 0.027 16.2 1.38–190.76
Age at diagnosis 0.28 1.0 0.97–1.13
Bilateral 0.06 0.3 0.11–1.05 0.027 0.2 0.03–0.82
Left side 0.85 0.9 0.36–2.33
Age[6 months at CR 0.66 0.8 0.29–2.16
Ossific nucleus present at CR 0.16 0.5 0.21–1.31
Bracing before CR 0.28 0.6 0.22–1.55
Traction before CR 0.018 3.5 1.23–9.66 0.019 5.8 1.34–25.43
Adductor tenotomy 0.11 2.7 0.81–9.04 0.37 2.2 0.39–12.70
Hip abduction angle 0.87 1.0 0.97–1.04
Hip abduction angle C50 0.57 1.4 0.47–4.08
CR closed reduction, CI confidence interval, Bracing Pavlik harness/hip abduction orthosis
Variables included in the multivariate model if univariate p-value\0.15 [34]
Table 3 Additional surgeries required after initial closed reduction





Acetabular augmentation 8 5
Femoral osteotomy 0 1
Acetabular augmentation ? femoral
osteotomy ? open reduction
1 0
Open reduction 1 0
Table 4 Clinical outcome of patients with and without AVN graded
on the scale by Brougham et al. [22]





Excellent—painless, no limp, negative
Trendelenburg, combined ROM[300
13 42
Good—painless, normal gait or slight limp,
negative or delayed positive Trendelenburg,
combined ROM\300 and[200
8 8
Fair—painless or occasional ache, limp and/or
Trendelenburg sign and/or combined ROM
[150 and\200
8 3
Poor—pain (exercise-related or interfering
with function), positive Trendelenburg and/or
fixed deformity and/or combined ROM
\150
0 0
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bracing, adductor tenotomy, and hip abduction angle in
cast [18–20, 22–25, 29–31]. Brougham et al. reported on
184 patients who underwent closed reduction of 210 hip
dislocations and noted AVN in 99 (of 210 affected hips,
47 %) [22]. Risk of AVN was unaffected by age, gender,
laterality, previous use of hip abduction orthosis, or
adductor tenotomy. Sibin´ski et al. reported AVN in 36 %
of DDH hips (37 of 103 affected hips) treated with closed
reduction and cast immobilization [35]. Laterality, absence
of proximal femoral ossific nucleus, use of pre-reduction
traction, and hip abduction bracing did not affect the AVN
risk. However, the degree of initial dislocation (by the
To¨nnis classification) and age at onset of treatment were
significant risk factors of AVN. Carney et al., in their study
of 45 patients who underwent successful closed reduction
of a DDH hip, noted AVN in 17 (of 48 affected hips, 35 %)
and reported the presence of the proximal femoral ossific
nucleus and use of adductor tenotomy as significant pro-
tective factors resulting in lower risk/rate of AVN [36]. In a
study of 64 patients with developmental dislocation of the
hip (36 who underwent closed reduction, 28 who were
treated with open reduction), Pospischill et al. reported
AVN in 40 % of hips (31 of 78 hips) and identified open
reduction combined with concomitant osteotomies, redis-
location, and need for secondary procedures after initial
reduction as risk factors of AVN. Age, preliminary trac-
tion, and spica cast immobilization were not found to
increase the risk of AVN [24].
In this series of 82 hips, the incidence of AVN was 35 %
(29 of 82 affected hips). Similar to previous studies, a large
number of risk factors for AVN after closed reduction and
spica casting for a dislocated or subluxated hip were
comprehensively reviewed. One specific focus of the study
was the effect of hip abduction angle on the risk of AVN,
in particular, whether the effects of hip abduction angle
occur in an age-dependent manner.
In this series, gender was found to be a significant risk
factor of AVN, with seven (of eight, 88 %) affected hips in
males compared to 21 (of 62, 34 %) hips in females
developing AVN (p = 0.027). A trend toward higher risk
of AVN in male patients has been previously reported;
however, it is unclear why male patients would be at higher
risk [22, 37]. Similar to previous studies, laterality (right
vs. left) in this series was not a significant risk factor of
AVN (p = 0.85) [22, 35]. But unlike previous studies, this
study revealed a decreased likelihood of developing AVN
in patients undergoing treatment for bilateral DDH
(p = 0.027). Morbi et al. found an increased risk of AVN
in patients treated for bilateral DDH (33.3 %, 24 of 72
hips) compared to unilateral cases (11.2 %, 25 of 224 hips)
[38]. Previous studies (like that of Morbi et al.) reporting
an increased risk of AVN for bilateral DDH, however, have
included patients treated with (closed and) open reduction
[38, 39]. The true effect of bilaterality on the risk of AVN
is not clear from this study, as it was limited to patients
undergoing closed reduction alone and excluded patients
treated with open reduction.
The use of pre-reduction traction was found to be sig-
nificantly associated with the development of AVN, with
an increased rate of AVN in patients who had undergone
pre-reduction traction (65 vs. 32 %) (p = 0.019). The
higher risk of AVN in patients who underwent pre-reduc-
tion traction conflicts with traditional thinking that traction
can decrease the risk of AVN, as reported in multiple
studies [12, 28, 40, 41]. These multiple studies explain that
pre-reduction traction can decrease the need for open
reduction and, thereby, reduce the risk of AVN. The exact
relationship between pre-reduction traction and AVN,
however, is unclear, as other studies have not found a
decreased rate of open reduction or AVN with pre-reduc-
tion traction [8, 22, 24, 35, 42, 43]. Subgroup analysis was
performed to determine whether history of prior brace
treatment (Pavlik harness or hip abduction orthosis) influ-
enced the role of pre-reduction traction and risk of AVN.
Four of the 17 patients (five affected hips, one bilateral
case) who underwent pre-reduction traction had history of
failed brace treatment. The risk of AVN remained
increased in patients who had undergone pre-reduction
traction—whether they had history of prior brace treatment
or not (p[ 0.99). The risk of AVN in pre-reduction trac-
tion patients was also increased regardless of the type of
traction (longitudinal vs. overhead-vertical) (p = 0.71).
Similar to other studies, the risk of AVN in this series
was not affected by: presence of proximal femoral ossific
nucleus, preliminary/history of hip abduction bracing, and
adductor tenotomy [22–24, 35, 37, 44]. Upon initial
Table 5 Relationship between AVN and clinical and radiographic outcomes: results of the univariate and multivariate analyses
Outcomes Univariate p-value Odds ratio 95 % CI Multivariate p-value Odds ratio 95 % CI
Acetabular index angle at final follow-up 0.59 1.0 0.95–1.09
Center edge angle at final follow-up 0.11 1.0 0.93–1.01 0.13 1.0 0.88–1.02
Excellent/good vs. fair/poor clinical outcome 0.011 0.2 0.38–0.65 0.049 0.2 0.04–0.99
Additional surgery required 0.06 2.6 0.95–7.27 0.034 4.6 1.12–18.62
Variables included in the multivariate model if univariate p-value\0.15 [34]
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analysis, hip abduction in the spica cast did not appear to
affect the risk of AVN (p = 0.87): mean abduction angle
of 57.3 (37–81) in hips without AVN compared to 57.7
(36–82) in hips that developed AVN. However, upon closer
inspection of younger patients (less than or equal to
6 months of age at the time of the closed reduction pro-
cedure), abduction in the spica cast greater than or equal to
50 did significantly increase the risk of AVN (p = 0.007).
Further analysis was performed to explore whether it was
age and/or the presence of ossific nucleus that influenced
this higher risk of AVN with high hip abduction angle. The
risk of AVN remained increased in younger patients with
hip abduction angle greater than 50 whether proximal
femoral ossific nucleus was present or not (p = 0.53).
Also, in all patients without proximal femoral ossific
nuclei, hip abduction angle C50 did not increase the risk
of AVN (p = 0.29).
Previous literature considering excessive hip abduction
as a potential risk factor of AVN lacks a consistent con-
clusion. Older reports by Salter et al. [18] and Gage and
Winter [19] suggest extreme positions of abduction as a
potential contributor to the development of AVN. In the
years following, this has been both corroborated, in reports
from Smith et al. [45] and Gregosiewicz and Wo´sko [29],
and contradicted, as reported by Stanton and Capecci [21].
While our initial analysis of all 70 patients found no sig-
nificant association between hip abduction and AVN, a
more in-depth look identified a positive association in a
subset of patients who underwent closed reduction at
B6 months of age. Also notable was that, within this group,
AVN only developed in patients 3–6 months of age at the
time of closed reduction. This age-dependent association is
consistent with prior clinical, experimental, and anatomical
investigations which describe a changing vascular structure
mid-way through the first year of life, with significant
vulnerabilities to extreme abduction in its transition from
bilateral to unilateral supply [18, 23, 27, 46–50]. In the
future, a gadolinium-enhanced perfusion magnetic reso-
nance imaging (MRI) after closed reduction/spica casting
may help to decrease the risk of AVN by allowing for
adjustments in the treatment protocol, including abduction
angle in the spica cast, while maintaining perfusion/vas-
cularity of the femoral head [51].
Outcome when AVN develops after closed reduction
procedure for DDH can be compromised. The development
of AVN increased the likelihood of subsequent surgery
(p = 0.034), most commonly an acetabular augmentation
procedure (13 cases), such as a Salter or Dega pelvic
osteotomy. Most commonly, subsequent surgeries were
needed because of persistent acetabular dysplasia and/or
incomplete reduction. The development of AVN led to
poorer clinical grades, with eight (of 29, 28 %) AVN-
affected hips reported as fair to poor clinical outcome
compared to three (of 53, 6 %) non-AVN hips.
There were several limitations in our study. First,
because of its retrospective nature, the study was limited by
available patient data. Second, the study period of 23 years
was long, resulting in heterogeneity in treatment protocols.
Third, with multiple treating surgeons, the role of surgeon
skill is unclear and unknown. Finally, radiographic out-
come data is subject to rater reliability and image accuracy.
Despite the limitations, our study comprehensively exam-
ined risk factors for the development of AVN and out-
comes following closed reduction and spica casting for
DDH in a large patient pool treated at a single tertiary
pediatric center. It is also the first to report on the rela-
tionship of hip abduction angle and young age on the risk
of AVN.
In conclusion, although closed reduction and spica cast
application remain an effective and successful treatment
option for many patients with DDH, the development of
AVN following a closed reduction procedure can be
problematic, with our study reporting an incidence of
35 %. On the basis of our study, male gender and the use of
pre-reduction traction may increase the risk of AVN. The
degree of hip abduction appears to play a significant role in
the development of AVN in younger patients (less than or
equal to 6 months of age). Based on our results, the authors
recommend that abduction in spica casts should be limited
to less than 50 in children less than or equal to 6 months
of age.
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